File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1186/s13578-023-01188-z
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Article: The crucial regulatory role of type I interferon in inflammatory diseases
Title | The crucial regulatory role of type I interferon in inflammatory diseases |
---|---|
Authors | |
Issue Date | 21-Dec-2023 |
Publisher | BioMed Central |
Citation | Cell & Bioscience, 2023, v. 13 How to Cite? |
Abstract | Type I interferon (IFN-I) plays crucial roles in the regulation of inflammation and it is associated with various inflammatory diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and periodontitis, impactingpeople’s health and quality of life. It is well-established that IFN-Is affect immune responses and inflammatory factors by regulating some signaling. However, currently, there is no comprehensive overview of the crucial regulatory role of IFN-I in distinctive pathways as well as associated inflammatory diseases. This review aims to provide a narrative of the involvement of IFN-I in different signaling pathways, mainly mediating the related key factors with specific targets in the pathways and signaling cascades to influence the progression of inflammatory diseases. As such, we suggested that IFN-Is induce inflammatory regulation through the stimulation of certain factors in signaling pathways, which displays possible efficient treatment methods and provides a reference for the precise control of inflammatory diseases. |
Persistent Identifier | http://hdl.handle.net/10722/339361 |
ISSN | 2023 Impact Factor: 6.1 2023 SCImago Journal Rankings: 1.836 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ji, Ling | - |
dc.contributor.author | Li, Tianle | - |
dc.contributor.author | Chen, Huimin | - |
dc.contributor.author | Yang, Yanqi | - |
dc.contributor.author | Lu, Eryi | - |
dc.contributor.author | Liu, Jieying | - |
dc.contributor.author | Qiao, Wei | - |
dc.contributor.author | Chen, Hui | - |
dc.date.accessioned | 2024-03-11T10:35:59Z | - |
dc.date.available | 2024-03-11T10:35:59Z | - |
dc.date.issued | 2023-12-21 | - |
dc.identifier.citation | Cell & Bioscience, 2023, v. 13 | - |
dc.identifier.issn | 2045-3701 | - |
dc.identifier.uri | http://hdl.handle.net/10722/339361 | - |
dc.description.abstract | <p>Type I interferon (IFN-I) plays crucial roles in the regulation of inflammation and it is associated with various inflammatory diseases including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and periodontitis, impactingpeople’s health and quality of life. It is well-established that IFN-Is affect immune responses and inflammatory factors by regulating some signaling. However, currently, there is no comprehensive overview of the crucial regulatory role of IFN-I in distinctive pathways as well as associated inflammatory diseases. This review aims to provide a narrative of the involvement of IFN-I in different signaling pathways, mainly mediating the related key factors with specific targets in the pathways and signaling cascades to influence the progression of inflammatory diseases. As such, we suggested that IFN-Is induce inflammatory regulation through the stimulation of certain factors in signaling pathways, which displays possible efficient treatment methods and provides a reference for the precise control of inflammatory diseases.</p> | - |
dc.language | eng | - |
dc.publisher | BioMed Central | - |
dc.relation.ispartof | Cell & Bioscience | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.title | The crucial regulatory role of type I interferon in inflammatory diseases | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1186/s13578-023-01188-z | - |
dc.identifier.volume | 13 | - |
dc.identifier.eissn | 2045-3701 | - |
dc.identifier.issnl | 2045-3701 | - |